| Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period (NCT03714373) | Soleno Therapeutics, Inc. | 2018-10-01 |
| Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. (NCT03696342) | Laboratorios Sophia S.A de C.V. | 2018-10-01 |
| Synergetic B-cell Immunomodulation in SLE - 2nd Study. (NCT03747159) | Leiden University Medical Center | 2018-10-01 |
| Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding (NCT04499898) | Sherief Abd-Elsalam | 2018-10-01 |
| Effect of Some Drugs on Rheumatoid Arithritis Activity (NCT03770923) | Sherief Abd-Elsalam | 2018-10-01 |
| Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus (NCT03707171) | Third Military Medical University | 2018-10-01 |
| Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis (NCT02642861) | Tanta University | 2018-10-01 |
| Nitrite Infusion in High Risk Patients Undergoing Cardiopulmonary Bypass (NCT03331146) | University of Alabama at Birmingham | 2018-10-01 |
| Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis (NCT03720340) | Zhejiang Cancer Hospital | 2018-10-01 |
| HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT (NCT03662087) | Nanfang Hospital, Southern Medical University | 2018-10-01 |
| Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR. (NCT03898622) | Hospital Civil de Guadalajara | 2018-10-01 |
| HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B (NCT03780049) | Sun Yat-sen University | 2018-10-01 |
| Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients With Fasting Dysglycemia (NCT04107987) | University of Pavia | 2018-10-01 |
| Treatment of In-Stent Restenosis 2 Study (NCT03667313) | University Hospital Ostrava | 2018-10-01 |
| Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes (NCT03715582) | University of Sao Paulo General Hospital | 2018-10-01 |
| Evaluation of Obex® in Overweight and Obesity (NCT03541005) | Catalysis SL | 2018-10-01 |
| Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women. (NCT03686085) | Cairo University | 2018-09-30 |
| PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain (NCT03375515) | Fujian Cancer Hospital | 2018-09-29 |
| Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children (NCT03667053) | Zealand Pharma | 2018-09-28 |
| Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC (NCT03659916) | Albireo, an Ipsen Company | 2018-09-28 |
| Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC (NCT03629925) | Innovent Biologics (Suzhou) Co. Ltd. | 2018-09-28 |
| Natriuretic Effect of Amiloride in Relation to the Alpha Adducin Gene (ADD-AMI) RS4961 Variant (NCT06416735) | Ospedale San Raffaele | 2018-09-28 |
| Evaluation of Efficacy and Safety of SDN-037 (NCT03426267) | Sun Pharma Advanced Research Company Limited | 2018-09-28 |
| Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged 12 to <18 Years) (NCT03500094) | Amicus Therapeutics | 2018-09-27 |
| G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes (NCT03738865) | Xeris Pharmaceuticals | 2018-09-27 |
| A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM (NCT03723655) | Bristol-Myers Squibb | 2018-09-27 |
| Multimodal Biomarkers for Diagnosis and Prognosis in CAA (NCT03969732) | National Taiwan University Hospital | 2018-09-27 |
| Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer (NCT03682068) | AstraZeneca | 2018-09-27 |
| CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome) (NCT03566043) | REGENXBIO Inc. | 2018-09-27 |
| DE-117 Spectrum 5 Study (NCT03697811) | Santen Inc. | 2018-09-27 |
| A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX) (NCT03660059) | Astellas Pharma China, Inc. | 2018-09-27 |
| A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study (NCT03691662) | Santen Inc. | 2018-09-27 |
| Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy (NCT03703297) | AstraZeneca | 2018-09-27 |
| Photobiomodulation for Breast Cancer Radiodermatitis (NCT04059809) | AC Camargo Cancer Center | 2018-09-26 |
| Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year (NCT03700242) | Sanofi Pasteur, a Sanofi Company | 2018-09-26 |
| Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy (NCT03702374) | University of Guadalajara | 2018-09-26 |
| Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin (NCT03684642) | Sanofi | 2018-09-26 |
| Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism (NCT03364738) | Shire | 2018-09-26 |
| Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS (NCT03480022) | Woman's | 2018-09-26 |
| Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease (NCT03615924) | AstraZeneca | 2018-09-26 |
| Metformin Therapy in Non-diabetic AAA Patients (NCT03507413) | Medical University of Vienna | 2018-09-26 |
| Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage (NCT04149171) | Cristina Martinez | 2018-09-26 |
| Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke (NCT03728738) | University of Tennessee | 2018-09-25 |
| Conjugate Vaccine Against Meningococcus C a Brazilian Project (NCT02858570) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2018-09-25 |
| Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix (NCT03556839) | Grupo Español de Investigación en Cáncer de Ovario | 2018-09-25 |
| Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1) (NCT03577899) | Chengdu Kanghong Biotech Co., Ltd. | 2018-09-25 |
| Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). (NCT03573401) | Biofrontera Inc. | 2018-09-25 |
| A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (NCT03563742) | Janssen Research & Development, LLC | 2018-09-24 |
| Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) (NCT03633617) | Regeneron Pharmaceuticals | 2018-09-24 |
| Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder (NCT03715166) | Institut de Recherches Internationales Servier | 2018-09-24 |
| The Short-Term MBT Project (NCT03677037) | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 2018-09-24 |
| Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections (NCT03687255) | Allecra | 2018-09-24 |
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer (NCT03678025) | SWOG Cancer Research Network | 2018-09-24 |
| A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (NCT03570749) | Eli Lilly and Company | 2018-09-24 |
| Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement (NCT03506347) | Mayo Clinic | 2018-09-24 |
| Protein Plus: Improving Infant Growth Through Diet and Enteric Health (NCT03683667) | Johns Hopkins Bloomberg School of Public Health | 2018-09-23 |
| A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited) (NCT03528577) | Sun Pharmaceutical Industries Limited | 2018-09-22 |
| A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma (NCT03635983) | Bristol-Myers Squibb | 2018-09-21 |
| Plasma Lipoprotein Response to Glucagon-like Peptide-2 (NCT03422666) | University Health Network, Toronto | 2018-09-21 |
| Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption (NCT03710889) | Radius Health, Inc. | 2018-09-20 |
| Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients (NCT03567889) | Philogen S.p.A. | 2018-09-20 |
| Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping (NCT03548766) | Hamad Medical Corporation | 2018-09-20 |
| Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients with Ventilator Associated-pneumonia (NCT03581370) | University Hospital, Toulouse | 2018-09-20 |
| Extension Study for the Port Delivery System With Ranibizumab (Portal) (NCT03683251) | Hoffmann-La Roche | 2018-09-20 |
| The Effect of Cinnamon on Ovulation Induction in Women With Polycystic Ovary Syndrome (NCT03778099) | King Abdulaziz University | 2018-09-20 |
| The Effect of Ganglion Sphenopalatine Block (GSP-block) Versus Placebo on Postdural Puncture Headache (NCT03652714) | University Hospital Bispebjerg and Frederiksberg | 2018-09-19 |
| Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in G1b Treatment-Naïve, HCV-Infected Patients (NCT03496233) | Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo | 2018-09-19 |
| Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis (NCT03534284) | University of Washington | 2018-09-19 |
| Tight Versus Liberal Blood Glucose Control in Adult Critically Ill Patients (NCT03665207) | KU Leuven | 2018-09-18 |
| Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016) (NCT03583333) | Merck Sharp & Dohme LLC | 2018-09-18 |
| Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men (NCT04467697) | Marius Pharmaceuticals | 2018-09-18 |
| A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702) (NCT03520959) | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2018-09-18 |
| Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI) (NCT03358576) | Iterum Therapeutics, International Limited | 2018-09-18 |
| An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA (NCT03661996) | Centrexion Therapeutics | 2018-09-18 |
| Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly (NCT03739112) | Medicago | 2018-09-18 |
| Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate (NCT03659929) | Arbor Pharmaceuticals, Inc. | 2018-09-18 |
| Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency (NCT03817957) | Prof. Dr. Frank Behrens | 2018-09-18 |
| Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis. (NCT03658616) | Dr. August Wolff GmbH & Co. KG Arzneimittel | 2018-09-18 |
| Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults (NCT03357614) | Iterum Therapeutics, International Limited | 2018-09-18 |
| Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers (NCT03673462) | Sanofi Pasteur, a Sanofi Company | 2018-09-17 |
| Gent for Pharyngeal Gonorrhea (GC) (NCT03632109) | University of Washington | 2018-09-17 |
| Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of Pollutants (NCT03664882) | Sanofi | 2018-09-17 |
| Clinical Study Comparing Two Models of a Travoprost Intraocular Implant (NCT03868124) | Glaukos Corporation | 2018-09-17 |
| Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis (NCT03635749) | Beijing Tiantan Hospital | 2018-09-17 |
| Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest (NCT03640949) | Lars Wiuff Andersen | 2018-09-17 |
| Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole (NCT03572049) | University of Alabama at Birmingham | 2018-09-17 |
| Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris (NCT03650361) | Aleor Dermaceuticals Limited | 2018-09-17 |
| Study of A-101 Topical Solution for the Treatment of Common Warts (NCT03687372) | Aclaris Therapeutics, Inc. | 2018-09-17 |
| Impact of Fecal Microbiota Transplantation in Ulcerative Colitis (NCT03483246) | Assistance Publique - Hôpitaux de Paris | 2018-09-17 |
| Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease (NCT03566017) | Chiesi Farmaceutici S.p.A. | 2018-09-16 |
| Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC (NCT03665441) | ERYtech Pharma | 2018-09-15 |
| CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis (NCT03168256) | Can-Fite BioPharma | 2018-09-15 |
| Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study) (NCT03664141) | Assaf-Harofeh Medical Center | 2018-09-15 |
| Anesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine (NCT03725579) | Cairo University | 2018-09-15 |
| A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS) (NCT03606460) | Genentech, Inc. | 2018-09-14 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU) (NCT03615482) | Merck Sharp & Dohme LLC | 2018-09-14 |
| Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (NCT03090880) | Assistance Publique - Hôpitaux de Paris | 2018-09-14 |
| A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia (NCT03655678) | Vertex Pharmaceuticals Incorporated | 2018-09-14 |
| Effects of Biktarvy on CFR in Stable HIV Patients (NCT03656783) | Brigham and Women's Hospital | 2018-09-14 |
| A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study (NCT03691649) | Santen Inc. | 2018-09-14 |